Q4 2025 Holdings
Filed 2026-02-17 | 461 holdings | $367.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $260.5K | 3,451 | 0.1% |
| Biohaven LTD(BHVN) | COM | G1110E107 | $260.5K | 23,072 | 0.1% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $260.7K | 8,214 | 0.1% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $261.6K | 7,209 | 0.1% |
| Neurogene Inc(NGNE) | COM | 64135M105 | $262.0K | 12,716 | 0.1% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $262.7K | 9,671 | 0.1% |
| Inhibrx Biosciences Inc(INBX) | COM | 45720N103 | $264.1K | 3,343 | 0.1% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $264.6K | 13,949 | 0.1% |
| Summit Therapeutics Inc(SMMT) | COM | 86627T108 | $264.8K | 15,141 | 0.1% |
| Intellia Therapeutics Inc(NTLA) | COM | 45826J105 | $265.1K | 29,493 | 0.1% |
| Upstream BIO Inc(UPB) | COM | 91678A107 | $266.1K | 9,801 | 0.1% |
| Rapport Therapeutics Inc(RAPP) | COM | 75383L102 | $266.7K | 8,789 | 0.1% |
| Oruka Therapeutics Inc(ORKA) | COM | 687604108 | $267.2K | 8,814 | 0.1% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $268.5K | 3,371 | 0.1% |
| Annexon Inc(ANNX) | COM | 03589W102 | $268.7K | 53,527 | 0.1% |
| Beam Therapeutics Inc(BEAM) | COM | 07373V105 | $269.5K | 9,724 | 0.1% |
| Prokidney Corp(PROK) | SHS CL A | 74291D104 | $269.6K | 120,376 | 0.1% |
| CG Oncology Inc(CGON) | COM | 156944100 | $269.8K | 6,497 | 0.1% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $269.9K | 4,247 | 0.1% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $270.0K | 13,806 | 0.1% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $270.3K | 7,819 | 0.1% |
| Lexeo Therapeutics Inc(LXEO) | COM | 52886X107 | $270.4K | 27,230 | 0.1% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $270.5K | 63,491 | 0.1% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $270.5K | 5,342 | 0.1% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $270.6K | 6,037 | 0.1% |
| Arbutus Biopharma Corp(ABUS) | COM | 03879J100 | $271.7K | 56,483 | 0.1% |
| Compass Pathways PLC(CMPS) | SPONSORED ADS | 20451W101 | $272.4K | 39,471 | 0.1% |
| Wave Life Sciences LTD(WVE) | SHS | Y95308105 | $273.1K | 16,064 | 0.1% |
| Jade Biosciences Inc(JBIO) | COM NEW | 008064206 | $274.0K | 17,759 | 0.1% |
| Liquidia Corporation(LQDA) | COM NEW | 53635D202 | $274.9K | 7,969 | 0.1% |
| Erasca Inc(ERAS) | COM | 29479A108 | $274.9K | 73,896 | 0.1% |
| Zymeworks Inc(ZYME) | COM | 98985Y108 | $274.9K | 10,441 | 0.1% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $275.4K | 78,474 | 0.1% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $275.9K | 5,979 | 0.1% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $275.9K | 3,967 | 0.1% |
| Regenxbio Inc(RGNX) | COM | 75901B107 | $276.2K | 19,181 | 0.1% |
| Compass Therapeutics Inc(CMPX) | COM | 20454B104 | $276.9K | 51,556 | 0.1% |
| Immatics N.v(IMTX) | SHS | N44445109 | $278.2K | 26,497 | 0.1% |
| Rigel Pharmaceuticals Inc(RIGL) | COM | 766559702 | $279.4K | 6,524 | 0.1% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $279.5K | 11,263 | 0.1% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $280.3K | 33,130 | 0.1% |
| Tectonic Therapeutic Inc(TECX) | COM | 878972108 | $280.8K | 13,462 | 0.1% |
| MBX Biosciences Inc(MBX) | COM | 55287L101 | $281.0K | 8,910 | 0.1% |
| Palvella Therapeutics Inc NE(PVLA) | COM | 697947109 | $282.4K | 2,698 | 0.1% |
| Invivyd Inc(IVVD) | COM | 00534A102 | $283.2K | 114,668 | 0.1% |
| Maze Therapeutics Inc(MAZE) | COM | 578784100 | $283.6K | 6,846 | 0.1% |
| Mind Medicine Mindmed Inc(BRD1EUR) | COM NEW | 60255C885 | $283.8K | 21,198 | 0.1% |
| Engene Holdings Inc(ENGN) | COM | 29286M105 | $283.9K | 31,445 | 0.1% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $287.0K | 5,919 | 0.1% |
| Xeris Biopharma Holdings Inc(XERS) | COM | 98422E103 | $291.3K | 37,102 | 0.1% |